Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | SELL | P14151 | 1/20 | 0.57 |
| ▸ | SELP | P16109 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
| ▸ | TPMT | P51580 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | BLVRB | P30043 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL419245 | 0.86 | TDP1 (0.56) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL12683255 | 0.84 | TDP1 (0.70) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL13827071 | 0.84 | ALDH1A1 (0.52) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL1505827 | 0.83 | TDP1 (0.61) | TDP1MAPTHTTALDH1A1HSD17B10 | |
| SCHEMBL16173476 | 0.82 | CA12 (0.52) | TDP1MAPTALDH1A1POLBMEN1 | |
| SCHEMBL11026756 | 0.82 | MAPT (0.73) | TDP1MAPTHTTTPMTALDH1A1 | |
| SCHEMBL28841565 | 0.82 | TDP1 (0.58) | TDP1MAPTSELLSELPALDH1A1 | |
| SCHEMBL6474772 | 0.82 | TDP1 (0.58) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL22245019 | 0.81 | TDP1 (0.56) | TDP1MAPTSELLSELPTPMT | |
| SCHEMBL27544371 | 0.81 | TDP1 (0.51) | TDP1MAPTSELLSELPHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2470632-A1 | IMPROVED WASHING PERFORMANCE USING RADICAL TRAPS | Henkel AG & Co. KGaA (DE) | 2012-07-04 | — | — | EP | claimed |
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | HENKEL AG & CO. KGAA (DE) | 2012-06-21 | — | — | US | claimed |
| WO-2011023716-A1 | IMPROVED WASHING PERFORMANCE USING RADICAL TRAPS | HENKEL AG & CO. KGAA (DE) | 2011-03-03 | — | — | WO | claimed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20210397090-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION AND METHOD FOR FORMING RESIST PATTERN USING THE SAME | NISSAN CHEMICAL CORPORATION (JP) | 2021-12-23 | — | — | US | disclosed |
| US-20140309220-A1 | BENZOXAZINES AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED | 2014-10-16 | — | — | US | disclosed |
| US-20140309220-A1 | BENZOXAZINES AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED | 2014-10-16 | — | — | US | disclosed |
| CN-102998924-A | Toner | CANON KK | 2013-03-27 | — | — | CN | disclosed |
| CN-102789146-A | Toner | CANON KK | 2012-11-21 | — | — | CN | disclosed |
| CN-102789147-A | Toner | CANON KK | 2012-11-21 | — | — | CN | disclosed |
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | HENKEL AG & CO. KGAA (DE) | 2012-06-21 | — | — | US | disclosed |
| US-4191841-A | DEMETHYLATION USING AN ALKALI HYDROXIDE AND ETHYLENE GLYCOL | SOCIETE FRANCAISE HOECHST (FR) | 1980-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309220-A1 | BENZOXAZINES AS MODULATORS OF ION CHANNELS | KCNJ1, KCNJ2, KCNJ11 | TDP1 2594/4885MAPT 1992/4885SELL 4204/4885 |
| US-20120157370-A1 | WASHING PERFORMANCE USING RADICAL TRAPS | MPO, DNASE1, PLD4 | TDP1 201/4885MAPT 2017/4885SELL 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.